SlideShare ist ein Scribd-Unternehmen logo
1 von 58
Downloaden Sie, um offline zu lesen
ANTIMALARIAL AGENTS
PREPARED BY:
MR. DHARMENDRASINH A. BARIA
ASSISTANT PROFESSOR,
DEPARTMENT OF PHARMACEUTICAL CHEMISTRY
SMT. S. M. SHAH PHARMACY COLLEGE, MAHEMDABAD
INTRODUCTION
• Malaria, one of the most widespread diseases, is caused by a plasmodium
parasite and is transmitted to humans by the female anopheles mosquito.
Plasmodium belongs to the class of protozoa known as sporozoa.
• Mainly four species of plasmodium typically cause human malaria are
plasmodium falciparum, p. Vivax, P. Malariae and P. Ovale .
• A 5th species, P. Knowlesi, is primarily a pathogen of monkeys, but has recently
been recognized to cause illness, including severe disease, in humans in asia.
• Although all species may cause significant illness, p. Falciparum is responsible
for the majority of serious complications and death.
LIFE CYCLE OF THE MALARIAL PARASITE
• An anopheles mosquito inoculates plasmodium sporozoites to initiate human
infection. Circulating sporozoites rapidly invade liver cells, and exoerythrocytic
stage tissue schizonts mature in the liver. Merozoites are subsequently released
from the liver and invade erythrocytes.
• Only erythrocytic parasites cause clinical illness. Sexual stage gametocytes also
develop in erythrocytes before being taken up by mosquitoes, where they develop
into infective sporozoites.
THERAPEUTIC CLASSIFICATION
1. Causal prophylaxis: (primary tissue schizonticides)
• Drugs prevent the maturation of or destroy the sporozoites within the infected
hepatic cell- thus prevent erythrocytic invasion
• Primaquine, proguanil
• Primaquine – for all species of malaria but not used due to its toxic potential
• Proguanil- primarily for P. Falciparum and not effective against P. Vivax (weak
activity), rapid development of resistance
2. Supressives prophylaxis:
• Supress the erythrocytic phase and thus attack of malarial fever can be used as
prophylactics
• Chloroquine, proguanil, mefloquine, doxycycline
3. Clinical cure: Erythrocytic Schizonticides
• Erythrocytic schizontocides are used to terminate episodes of malarial fever
• Fast acting high efficacy drugs:
• Chloroquine, quinine, mefloquine, halofantrine, artemicinin
• Used singly to treat malaria fever
• Faster acting, preferably used in falciparum malaria where delayed treatment
may lead to death even if parasites are clear from blood
• Slow acting low efficacy drugs:
• Proguanil, pyrimethamine, sulfonamides, tetracyclines
• Used only in combination
4. Radical curatives:
• Drug attack exoerythrocytic stage (hypnozoites) given with clinical curative for
the total eradication of the parasite from the patient’s body
• Radical cure of the P. Falciparum malaria can be achieved by suppressives only
• For radical cure of P. Vivax infection, primaquine and proguanil are effective
5. Gametocidal:
• Removal of male and female gametes of plasmodia formed in the patient’s
blood
• It has no benefit for treated patient
• Primaquine and artemisinins are highly effective against gametocytes of all
species
CHEMICAL CLASSIFICATION
Classes Drugs
1. 4-aminoquinolines Chloroquine (CQ), amodiaquine (AQ),
Piperaquine
2. Quinoline-methanol Mefloquine
3. Cinchona alkaloid Quinine, quinidine
4. Biguanide Proguanil (chloroguanide)
5. Diaminopyrimidine Pyrimethamine
6. 8-aminoquinoline Primaquine, tafenoquine
7. Sulfonamides and
sulfone
Sulfadoxine, sulfamethopyrazine,
dapsone
8. Amino alcohols Halofantrine, lumefantrine
10. Naphthyridine Pyronaridine
11. Naphthoquinone Atovaquone
12. Antibiotics Tetracycline, Doxycycline, Clindamycin
1. 4-AMINOQUINOLINES
N
NH
CH3
N
C2H5
C2H5
Cl
Chloroquine
N
NH
C H 3
N
C 2
H 4
O H
C 2
H 5
C l
H y d r o x y c h l o r o q u i n e
NCl
NH
NH
C2H5
C2H5
OH
Amodiaquine
CHLOROQUINE:
• It has activity against the blood stages of plasmodium ovale, P. Malariae, and
susceptible strains of P. Vivax and P. Falciparum.
• Widespread resistance in most malaria-endemic countries has led to decline in its
use for the treatment of p. Falciparum, although it remains effective for treatment of
P. Ovale, P. Malariae and, in most regions, P. Vivax.
• Mechanism of action :
• Binds to and inhibits dna and rna polymerase; interferes with metabolism and
hemoglobin utilization by parasites; inhibits prostaglandin effects.
• The parasite digests the human hemoglobin in order to get amino acid, but the
problem here is that the heme part of hb is toxic to the parasite.
• To overcome this obstacle, the parasite has developed an enzyme responsible for
polymerization of heme. To form insoluble crystals called hemozoin which are
collected in vacuoles.
• Chloroquine enters parasite cell by simple diffusion. Chloroquine then becomes
protonated as the digestive vacuole is known to be acidic (pH 4.7), chloroquine
then cannot leave by diffusion. Chloroquine inhibits polymerization of heme and
accumulation of heme.
• Chloroquine binds to heme (or fp) to form what is known as the fp-chloroquine
complex, this complex is highly toxic to the cell and disrupts membrane function.
Action of the toxic compound results in cell lysis and ultimately parasite cell
autodigestion.
MECHANISM OF ACTION
MECHANISM OF ACTION :
• RESISTANCE RESULTS FROM ENHANCED EFFLUX OF THE PARASITE VESICLE
EXPRESSION OF THE HUMAN MULTI DRUG RESISTANCE TRANSPORTER P-
GLYCOPROTEIN.
PHARMACOLOGICAL ACTIONS
1. Antimalarial activity:
• High against erythrocytic forms of vivax, ovale, malariae & sensitive strains of
falciparum
• Gametocytes of vivax
• No activity against tissue schizonts
• Resistance develops due to efflux mechanism
2. Other parasitic infections:
• Giardiasis, taeniasis, extrainstestinal amoebiasis
3. Other actions:
• Depressant action on myocardium, direct relaxant effect on vascular smooth
muscles, antiinflammatory, antihistaminic , local anaesthetic
Adverse drug reactions
Intolerance:
• Nausea, vomiting, anorexia
• skin rashes, angioneurotic edema, photosensitivity, pigmentation,
exfoliative dermatititis
• Long term therapy may cause bleaching of hair
• Rarely thrombocytopenia, agranulocytosis, pancytopenia
Ocular toxicity:
• High dose prolonged therapy
• Temporary loss of accommodation
• Lenticular opacities, subcapsular cataract
Adverse drug reactions
• Retinopathy:
• Constriction of arteries, edema, blue black pigmentation, constricted field of
vision.
• CNS:
• Insomnia, transient depression seizures, rarely neuromyopathy &
ototoxicity
• CVS:
• ST & T wave abnormalities, abrupt fall in bp & cardiac arrest in children
reported
THERAPEUTIC USES
1. HEPATIC AMOEBIASIS
2. GIARDIASIS
3. CLONORCHIS SINENSIS
4. RHEUMATOID ARTHRITIS
5. DISCOID LUPUS ERYTHEMATOSUS
6. CONTROL MANIFESTATION OF LEPRA REACTION
7. INFECTIOUS MONONUCLEOSIS
• Hydroxy chloroquine:
 Less toxic, properties &uses similar
• Amodiaquine:
 As effective as chloroquine
 Pharmacological actions similar
 Chloroquine resistant strains may be effective
 Adverse events: GIT, headache , photosensitivity, rarely agranulocytosis
 Not recommended for prophylaxis
• Contraindications:
1.Psoriasis or porphyria
2.Visual field abnormalities or myopathy
3.Ca and mg containing antacid interfere with absorption
4.Used with caution in liver disease or neurologic or hematologic disorders.
N
NHR
R1
Cl
1
2
3
45
6
7
8
Dialkylaminoalkyl side chain
1. 2-5 carbon atoms between the nitrogen atoms,particularly 4-diethylamino-
1-methylbutylamino side chain is optimal for activity as in chloroquine.
2. The tertiary amine is important.
3. Introduction of unsaturation in the side chain was not detrimental to activity.
4. Substitution of a hydroxy on one of the ethyl groups in tertiary amine
(hydroxy quinoline) generally reduces toxicity and increases the plasma
concentration. This is one of the metabolites of chloroquine.
5. Incorporation of an aromatic ring in the side chain e.g. in Amodiaquine,
gives a compound with reduced toxicity and toxicity.
Introduction of chloro
group at this position is
optimal for activity
Introduction of methyl
group at this position
reduces activity
d-Isomer of chloroquine is somewhat less toxic than l-isomer
SAR of 4-aminoquinolines
2. QUINOLINE-METHANOL
N
CF3
NH
OH
H
CF3
Mefloquine
 Mefloquine, is marketed as the R,S-isomer.
 Mefloquine's effectiveness in the treatment and prophylaxis of
malaria is due to the destruction of the asexual blood forms of
the malarial pathogens that affect humans, Plasmodium
falciparum, P. vivax, P. malariae, P. ovale.
 Used in chloroquine-resistant strains of P. falciparum and
other species.
 Has strong blood schizonticidal activity against P. falciparum
and P. vivax, it is not active against hepatic stages or
gametocytes.
Adverse effects
 Mefloquine is bitter in taste
 At high doses: Nausea, vomiting, diarrhea, abdominal pain,
CONTRAINDICATIONS
• Hypersensitivity to mefloquine, related compounds (eg, quinine and quinidine),
or any component of the formulation; prophylactic use in patients with a history
of seizures or severe psychiatric disorder (including active or recent history of
depression, generalized anxiety disorder, psychosis, or schizophrenia).
Drug interactions
• Cardiac arrests are possible if mefloquine is taken concurrently with quinine or
quinidine.
Uses
• Effective for multidrug resistant p. Falciparum
• However its use is restricted due to its toxicity, cost and long half life
3. CINCHONA ALKALOIDS
N
OH
N
H
R2
R1
1
2
3
45
6
7
8
1
2
3
4
5
6
7
8
9
• Quinine is a l-isomer of alkaloid obtained from cinchona bark and quinidine
(antiarrhythmic) is its d-isomer.
• An effective erythrocytic schizontocide as suppressive and used to prevent or
terminate attacks of vivax, ovale, malariae, sensitive falciparum. less effective and
more toxic than chloroquine.
• Moderately effective against hepatic form (pre-exoerythrocyte and gametocytes).
PHARMACOLOGICAL ACTIONS
1. Antimalarial action:
• Erythrocytic forms of all malarial parasites including resistant falciparum
strains .
• Gametocidal for vivax & malariae
2. Cardiovascular:
• Depresses myocardium, ↓ excitability, ↓ conductivity, ↑ refractory period,
profound hypotension IV.
3. Miscellaneous actions:
• Mild analgesic, antipyretic activity , stimulation of uterine smooth muscle,
curaremimitic effect
4. Local irritant and anaesthetic
• Resurgence of interest in quinine is due to the fact that most chloroquine and
multidrug-resistant strains of P. Falciparum still respond to it.
• Quinine + tetracycline has been the standard treatment of complicated malaria.
Adverse drug reactions
Cinchonism:
• Tinnitus, nausea & vomiting.
• Headache mental confusion, vertigo, difficulty in hearing & visual
disturbances
• Diarrhoea , flushing & marked perspiration.
• Still higher doses, exaggerated symptoms with delirium, fever, tachypnoea,
respiratory depression, cyanosis.
Black water fever: a fatal condition in which acute hemolytic anemia is associated
with renal failure.
Cardiovascular toxicity: cardiac arrest, hypotension ,fatal arrhythmias
Black water fever
because of
methanol group
CONTRAINDICATIONS :
Hypersensitivity to quinine or any component of the formulation;
hypersensitivity to mefloquine or quinidine (cross sensitivity
reported); prolonged QT interval; myasthenia gravis; optic neuritis;
G6PD deficiency; history of black water fever; thrombotic
thrombocytopenia purpurea, hemolytic uremic syndrome,
thrombocytopenia
N
N
OH
H
R1
H
1'
2'
3'4'
5'
6'
7'
8'
9
1
2
3
4
5
6
7
8
Assymmetry at this positions is not essential
for antimalarial activity
Quinuclidine portion is not necessary
for activity; however, an alkyl tertiary
amine attached at C-9 is important
1. Modification of the secondary alcohol at C-9,
through oxidation, esterification diminishes
activity.
2.The configuration at positions 8 and 9 affects
the juxtaposition of the hydroxyl group and
the non-aromatic nitrogen atom, a relationship
that is associated with antimalarial activity.
Activity usually enhanced by the
introduction of a halogen at this
position.
Quinoline Ring
1. Presence of methoxy group in quinine is not
essential.
2. Replacement of methoxy group by a halogen,
especially chlorine, enhances activity.
3. A further increase in activity resulted from
the introduction of a phenyl group at position 2'.
4. It was discovered that high activity without
phototoxicity could be attained by blocking
position 2' with a trifluoromethyl group, a finding
that eventually led to development of mefloquine.
SAR Of Quinine
4. BIGUANIDES
N
H
NH2N
H
NH2
NH
CH
(CH3)2
Proguanil
 It is an early example of a prodrug.
 It is a slow-acting erythrocytic schizontocide which also
inhibits the preerythrocytic stage of P. falciparum.
Gametocytes exposed to proguanil are not killed but fail to
develop properly in the mosquito.
 It is cyclized in the body to a triazine derivative
(cycloguanil) which inhibits plasmodial DHFRase in
preference to the mammalian enzyme.
 Resistance to proguanil develops rapidly due to mutational
changes in the plasmodial DHFRase enzyme.
Conversion of proguanil to cycloguanil by CYP2C19
Adverse effects
• Mild abdominal upset, vomiting
• Occasional stomatitis
• Haematuria, rashes and transient loss of hair
• Note : safe during pregnancy
Mechanism of action of anti folates
5. DIAMINOPYRIMIDINE
C
H2 N
N
NH2
NH2
MeO
MeO
MeO
N
N
NH2
Cl
NH2
C2
H5
Trimethoprim Pyrimethamine
 Slow acting erythrocytic schizontocide
 Direct inhibitor of plasmodial dihydrofolate reductase (DHFRase)
 Conversion of dihydrofolic acid to tetrafolic acid is inhibited
 High doses inhibits Toxoplasma gondi
 Resistance develops by mutation in DHFRase enzyme
 Diaminopyrimidine more potent than proguanil & effective against erythrocytic
forms of all species.
Pyrimethamine
Adverse effects
• Occasional nausea and rashes
• Folate deficiency rare
• Megaloblastic anaemia and granulocytopenia with higher dose
• Can be treated with folinic acid
• Combined with a sulfonamide (S/P) or dapsone for treatment of falciparum
malaria
SULFADOXINE - PYRIMETHAMINE
• Sequential blockade
• Sulfadoxine 500 mg + pyrimethamine 25 mg, 3
tablets once for acute attack
• Not recommended for prophylaxis
• Effective blood schizontocide against plasmodium
falciparum
• Treatment and prophylaxis of falciparum malaria
resistant to chloroquine
Adverse effects
• Mild GIT upset
• Megaloblastic anemia, bone marrow depletion
• Rashes, urticaria, serum sickness, drug fever
• Exfoliative dermatitis, stevens johnson syndrome
• Nephrotoxicity
Uses:
• Single dose treatment of uncomplicated chloroquine resistant falciparum malaria
• Patients intolerant to chloroquine
• First choice treatment for toxoplasmosis
6. 8-AMINOQUINOLINE
N
MeO
NH
CHCH2CH2CH2NH2CH3
N
MeO
NH
CHCH2CH2CH2N(C2H5)2CH3
Primaquine Pamaquine
N
MeO
NH
N
H
CH(CH3)2
Pentaquine
N
MeO
NH
NH2
CH3
Quinocide
Primaquine:
• It is the only 8-aminoquinoline in clinical use.
• It is largely used to prevent relapse of p. Ovale and P. Vivax malaria by eliminating
dormant hypnozoites, and it also has activity against the pre-erythrocytic stage
and gametocytes of P. Falciparum.
• It is not used for prophylaxis. Its spectrum of activity is one of the narrowest of the
currently used antimalarial drugs being indicated only for exoerythrocytic P. Vivax
malaria
Mechanism of action primaquine:
• Not clear, its converted & produces active oxygen interfere with plasmodial
mitochondrial function
Uses of primaquine
1. Radical cure
A) P.Vivax & ovale :
• Given in acute attack or throughout incubation period
• Prevents relapse
Prophylactically: before & after leaving the endemic area to eradicate hepatic forms
• Effective vector control is possible or used in areas of low transmission
B) falciparum malaria:
• 45mg with chloroquine used like gametocidal & cut down transmission or where
effective control is needed.
Adverse drug reaction
Therapeutic doses:
• Haemolysis & methaemoglobinaemia commonly seen in g6pd deficiency
• Causes nausea, headache, epigastric pain &abdominal cramps on empty stomach
• Rarely : leucopenia, leucocytosis & agranulocytosis
• Precaution – primaquine
• Should not be given during pregnancy because fetus is glucose-6-phosphate
dehydrogenase ( g-6-pd) deficient
7. SULFONAMIDES AND SULFONE
Dapsone
N
N
NH2 S N
H
O
O
OMeMeO
Sulfadoxine
8. Amino alcohols
• Structurally, halofantrine differs from all other antimalarial drugs. It is a good
example of drug design that incorporates bioisosteric principles as evidenced by
the trifluromethyl moiety.
• Halofantrine is a schizonticide and has no affect on the sporozoite, gametocyte,or
hepatic stages.
• It is active against strains resistant to chloroquine, pyrimethamine, quinine.
• Cross-resistance in falicparum infection occurred .
• Erratic bioavailability, lethal cardio toxicity & cross resistance to mefloquine limited
its use.
• Now a days used only when no other alternative available
ADR:-
• Abdominal pain, headache, transient increase in hepatic enzymes, cough,
pruritus, lengthening of qt interval. May cause hemolytic anemia &
convulsions. Reserved for infection caused by resistant organisms.
Contraindications: with mefloquine.
• Patients with cardiac conduction defects.
• In pregnancy → embriotoxic in animals
9. SESQUITERPINE LACTONES
• The artemisinin series are the newest
of the antimalarial drugs and are
structurally unique when compared
with the compounds previously and
currently used.
• The parent compound, artemisinin, is
a natural product extracted from the
dry leaves of artemisia annua (sweet
wormwood).
• All of the compounds given in figure
are active against the plasmodium
genera that cause malaria.
PLANT- ARTEMISIA ANNUA
• The key structure characteristic
appears to be a “trioxane” consisting
of the endoperoxide and dioxepin
oxygens.
• Note that the stereochemistry at
position 12 is not critical.
• These are the artimisinin derivatives
used in malaria:
1. Artesunate
2. Artemether
3. Arteether
4. Arterolane
MECHANISM OF ACTION
• These compounds contains endoperoxide bridge.
• Endoperoxide bridge interacts with heme in parasite.
• Heme iron cleaves this endoperoxide bridge.
• There is generation of highly reactive free radicals which damage parasite
membrane by covalently binding to membrane proteins.
• They act rapidly, killing blood stages of all plasmodium species and reducing the
parasite biomass.
• Artemisinins have the fastest parasite clearance times of any antimalarial.
• Artemisinins are active against gametocytes, the parasite form that is infectious to
mosquitoes, and their use has been associated with reduced malaria transmission.
• Safe & 10-100 times potent compared to other antimalarials.
ANTIMALARIAL ACTION
ARTEMISININ-BASED COMBINATION THERAPIES
• In general, artemisinins should not be used as a single agent, to prevent
emergence of drug resistance and to avoid the need for prolonged therapy.
• Artemisinin-based combination therapy (acts) combine the highly effective short-
acting artemisinins with a longer-acting partner to protect against artemisinin
resistance and to facilitate dosing convenience.
• Acts are typically administered for 3 days and are often available in fixed-dose
tablets.
• Four acts are recommended by the who for the treatment of uncomplicated
malaria: artemether-lumefantrine, artesunate-amodiaquine, artesunate-
mefloquine and artesunate-sulfadoxine-pyrimethamine.
ARTEMISININS
• Intravenous artesunate is used for the treatment of severe malaria.
• It is superior to quinine for treatment of severe malaria with respect to clearing
parasitemia and reducing mortality.
• Given the short half-life of artemisinins, intravenous therapy must be followed
by a longer acting agent once the patient is able to tolerate oral medication.
• If used alone (via the parenteral, rectal or oral route), artesunate must be
administered for 5-7 days.
• Treatment for less than 5 days results in recurrent parasitemia several weeks
after therapy due to the very short duration of action, rather than to artemisinin
resistance.
• Artemisinins are generally well tolerated.
• Type 1 hypersensitivity to the artemisinin compounds has been reported.
• Adverse effects of orally-administered artemisinins demonstrated transient
neurological abnormalities (nystagmus and disturbances in balance); these effects
resolved without lasting sequelae.
Advantages of act
• Rapid clinical and parasitological cure
• High cure rates(>95%) and low recrudescence rate
• Absence of parasite resistance
• Good tolerability profile
• Dosing schedule is simpler
1. ARTESUNATE - SULFADOXINE + PYRIMETHAMINE
(AS-S/P)
• First line drug for uncomplicated falciparum malaria.
• Not effective against multidrug-resitant strains which are non responsive to
s/p.
• Fewer side effects than as/mq.2. Artesunate /mefloquine (AS/MQ)
• Highly effective and well tolerated in uncomplicated falciparum
malaria
3. Artemether - lumefantrine (AS/LF)
 Clinical efficacy: 95-99%
 Must be administered with fatty food or milk to allow absorption and ensure
adequate blood level of AS/LF
 Quickly reduces parasite biomass, resolve symptoms, prevent recrudescence, check
gametocyte population
4. DIHYDROARTEMISININ (DHA)-PIPERAQUINE
• Used in dose ratio of 8:1 for multidrug resistant plasmodium falciparum.
• Good safety profile and even tolerated by children (>98% response rate).
5. ARTESUNATE-AMODIAQUINE(AS/AQ)
• First line therapy of uncomplicated falciparum malaria
• To be taken twice daily for three day treatment
Other recently developed ACT are:
6. ARTEROLANE-PIPERAQUINE
• Acts rapidly at all stages of asexual schizogony of malarial parasite including
multidrug resistant P. Falciparum
7. ARTESUNATE-PYRONARIDINE
• Under clinical trial
10. NAPHTHYRIDINE
 Newer drug from Mepacrine developed in china.
 Mechanism similar to chloroquine.
 High effective erythrocytic schizonticide, effective against
chloroquine sensitive & resistant vivax & falciparum malaria.
 Slow onset & long duration of action, concentrated in RBC.
 Water soluble, t1/2 : 7days
 Orally & parenterally used , well tolerated
 At high dose used analgesic/anti pyretic
11. NAPHTHOQUINONE
 Hydroxy naphthoquinone antiparasitic drug active against all
Plasmodium species.
 Rapid acting erythrocytic schizontocide & inhibits pre-
erythrocytic stage of falciparum.
 Also active against pneumocystis jiroveci & Toxoplasma
gondii.
 Combined with proguanil Where its resistant, reduces relapse
& which is synergistic.
 Collapses mitochondrial membrane interferes with
cytochrome electron transport.
12. ANTIBIOTICS
Tetracycline & doxycycline
 Erythrocytic schizonts are inhibited by all malarial parasite.
 Tetracycline used in combination with quinine in treatment of chloroquine
resistant as well vivax malaria.
 Avoid in children & pregnant women.
 Doxycycline used in places where high resistance present.
 200mg doxycycline combined with artesunate to treat
mefloquine/chloroquine/s-p resistant malaria.
 100mg/day of doxycycline used 2nd line prophylactic for short travels to
chloroquine resistant p. Falciparum.
CLINDAMYCIN:
• Slow erythrocytic schizontocide, bacteriostatic
• With quinine used in treatment of resistant P.Falciparum
• Its used where tetracyclines can not be used in pregnancy & children less
than 8 years old

Weitere ähnliche Inhalte

Was ist angesagt?

Antibiotics - Medicinal chemistry
Antibiotics - Medicinal chemistry Antibiotics - Medicinal chemistry
Antibiotics - Medicinal chemistry kencha swathi
 
Antimalarial drugs
Antimalarial drugsAntimalarial drugs
Antimalarial drugsAsra Hameed
 
Antimalarial agents
Antimalarial agentsAntimalarial agents
Antimalarial agentsGanesh Mote
 
Tetracycline sar
Tetracycline sarTetracycline sar
Tetracycline sarnaseefa
 
Quinolone antibacterials
Quinolone antibacterialsQuinolone antibacterials
Quinolone antibacterialsSuvarta Maru
 
Important Synthesis of Antiviral Drugs
Important Synthesis of  Antiviral DrugsImportant Synthesis of  Antiviral Drugs
Important Synthesis of Antiviral DrugsAnjali Bhardwaj
 
Aminoglycosides(medicinal chemistry by p.ravisankar)
Aminoglycosides(medicinal chemistry by p.ravisankar)Aminoglycosides(medicinal chemistry by p.ravisankar)
Aminoglycosides(medicinal chemistry by p.ravisankar)Dr. Ravi Sankar
 
Medicinal Chemistry of Hetrocyclic Compound
Medicinal Chemistry of Hetrocyclic CompoundMedicinal Chemistry of Hetrocyclic Compound
Medicinal Chemistry of Hetrocyclic CompoundPuja Ramu Basule
 
Medicinal chemistry-Anticancer agents
Medicinal chemistry-Anticancer agentsMedicinal chemistry-Anticancer agents
Medicinal chemistry-Anticancer agentsDHARMENDRA BARIA
 
antiviral drugs medicinal chemistry by padala varaprasad
antiviral drugs medicinal chemistry by padala varaprasadantiviral drugs medicinal chemistry by padala varaprasad
antiviral drugs medicinal chemistry by padala varaprasadVaraprasad Padala
 
Basic concepts and application of prodrug design
Basic concepts and application of prodrug designBasic concepts and application of prodrug design
Basic concepts and application of prodrug designProf. Aejaz Ahmed Boraji
 
Penicillins by Dr. Panchumarthy Ravisankar M.Pharm., Ph.D.
Penicillins by Dr. Panchumarthy Ravisankar M.Pharm., Ph.D.Penicillins by Dr. Panchumarthy Ravisankar M.Pharm., Ph.D.
Penicillins by Dr. Panchumarthy Ravisankar M.Pharm., Ph.D.Dr. Ravi Sankar
 
Antiprotozoal Drugs- Medicinal Chemistry-Pharmacy
Antiprotozoal Drugs- Medicinal Chemistry-PharmacyAntiprotozoal Drugs- Medicinal Chemistry-Pharmacy
Antiprotozoal Drugs- Medicinal Chemistry-PharmacyAkhil Nagar
 
Prodrugs - concept & Applications
Prodrugs - concept & ApplicationsProdrugs - concept & Applications
Prodrugs - concept & ApplicationsJanet Thomas
 
Anti-Malarial; 8-aminoquinolines
Anti-Malarial; 8-aminoquinolinesAnti-Malarial; 8-aminoquinolines
Anti-Malarial; 8-aminoquinolinesFahad Ullah
 
Penicillins, cephalosporins, amido penicillins
Penicillins, cephalosporins, amido penicillinsPenicillins, cephalosporins, amido penicillins
Penicillins, cephalosporins, amido penicillinsN K
 

Was ist angesagt? (20)

Antibiotics - Medicinal chemistry
Antibiotics - Medicinal chemistry Antibiotics - Medicinal chemistry
Antibiotics - Medicinal chemistry
 
Antimalarial drugs
Antimalarial drugsAntimalarial drugs
Antimalarial drugs
 
Antimalarial agents
Antimalarial agentsAntimalarial agents
Antimalarial agents
 
Tetracycline sar
Tetracycline sarTetracycline sar
Tetracycline sar
 
Quinolone antibacterials
Quinolone antibacterialsQuinolone antibacterials
Quinolone antibacterials
 
Important Synthesis of Antiviral Drugs
Important Synthesis of  Antiviral DrugsImportant Synthesis of  Antiviral Drugs
Important Synthesis of Antiviral Drugs
 
Aminoglycosides(medicinal chemistry by p.ravisankar)
Aminoglycosides(medicinal chemistry by p.ravisankar)Aminoglycosides(medicinal chemistry by p.ravisankar)
Aminoglycosides(medicinal chemistry by p.ravisankar)
 
Medicinal Chemistry of Hetrocyclic Compound
Medicinal Chemistry of Hetrocyclic CompoundMedicinal Chemistry of Hetrocyclic Compound
Medicinal Chemistry of Hetrocyclic Compound
 
Medicinal chemistry-Anticancer agents
Medicinal chemistry-Anticancer agentsMedicinal chemistry-Anticancer agents
Medicinal chemistry-Anticancer agents
 
Sulphonamide
SulphonamideSulphonamide
Sulphonamide
 
Med.chem sulfonamides
Med.chem  sulfonamidesMed.chem  sulfonamides
Med.chem sulfonamides
 
antiviral drugs medicinal chemistry by padala varaprasad
antiviral drugs medicinal chemistry by padala varaprasadantiviral drugs medicinal chemistry by padala varaprasad
antiviral drugs medicinal chemistry by padala varaprasad
 
Anti Fungal Drugs
Anti Fungal DrugsAnti Fungal Drugs
Anti Fungal Drugs
 
Basic concepts and application of prodrug design
Basic concepts and application of prodrug designBasic concepts and application of prodrug design
Basic concepts and application of prodrug design
 
Penicillins by Dr. Panchumarthy Ravisankar M.Pharm., Ph.D.
Penicillins by Dr. Panchumarthy Ravisankar M.Pharm., Ph.D.Penicillins by Dr. Panchumarthy Ravisankar M.Pharm., Ph.D.
Penicillins by Dr. Panchumarthy Ravisankar M.Pharm., Ph.D.
 
Antiprotozoal Drugs- Medicinal Chemistry-Pharmacy
Antiprotozoal Drugs- Medicinal Chemistry-PharmacyAntiprotozoal Drugs- Medicinal Chemistry-Pharmacy
Antiprotozoal Drugs- Medicinal Chemistry-Pharmacy
 
Prodrugs - concept & Applications
Prodrugs - concept & ApplicationsProdrugs - concept & Applications
Prodrugs - concept & Applications
 
Anti-Malarial; 8-aminoquinolines
Anti-Malarial; 8-aminoquinolinesAnti-Malarial; 8-aminoquinolines
Anti-Malarial; 8-aminoquinolines
 
Penicillins, cephalosporins, amido penicillins
Penicillins, cephalosporins, amido penicillinsPenicillins, cephalosporins, amido penicillins
Penicillins, cephalosporins, amido penicillins
 
Medicinal Chemistry of Diuretics
Medicinal Chemistry of DiureticsMedicinal Chemistry of Diuretics
Medicinal Chemistry of Diuretics
 

Andere mochten auch

Medicinal chemistry-beta lactam antibiotics
Medicinal chemistry-beta lactam antibioticsMedicinal chemistry-beta lactam antibiotics
Medicinal chemistry-beta lactam antibioticsDHARMENDRA BARIA
 
Basic aspects of Stereochemistry
Basic aspects of StereochemistryBasic aspects of Stereochemistry
Basic aspects of StereochemistryDHARMENDRA BARIA
 
Medicinal chemistry i
Medicinal chemistry  iMedicinal chemistry  i
Medicinal chemistry ipriya yadav
 
04.pharmacokinetics(1)
04.pharmacokinetics(1)04.pharmacokinetics(1)
04.pharmacokinetics(1)sisy10
 
Medicinal chemistry of Antiamoebic agents
Medicinal chemistry of Antiamoebic agentsMedicinal chemistry of Antiamoebic agents
Medicinal chemistry of Antiamoebic agentsGanesh Mote
 
medicinal chemistry of Antibiotic
medicinal chemistry of Antibiotic medicinal chemistry of Antibiotic
medicinal chemistry of Antibiotic Ganesh Mote
 
Cephalosporins- History,Classification,Sar,Synthesis,Mechanism of action,Uses...
Cephalosporins- History,Classification,Sar,Synthesis,Mechanism of action,Uses...Cephalosporins- History,Classification,Sar,Synthesis,Mechanism of action,Uses...
Cephalosporins- History,Classification,Sar,Synthesis,Mechanism of action,Uses...Dr. Ravi Sankar
 
Treament of malaria
Treament of malariaTreament of malaria
Treament of malariaRoto Robo
 
Mef n Taf Care Pack 1 3 mef and taf vets brief as at 8 feb 2016
Mef n Taf Care Pack 1 3 mef and taf vets brief as at 8 feb 2016Mef n Taf Care Pack 1 3 mef and taf vets brief as at 8 feb 2016
Mef n Taf Care Pack 1 3 mef and taf vets brief as at 8 feb 2016Wendy.J. Seymour
 
Lifecycle of malarial parasite
Lifecycle  of  malarial  parasite Lifecycle  of  malarial  parasite
Lifecycle of malarial parasite Soorej Jaiboi K
 
Reaxys Medicinal Chemistry
Reaxys Medicinal ChemistryReaxys Medicinal Chemistry
Reaxys Medicinal ChemistryReaxys
 
Parkinson disease by Petar Jesic
Parkinson disease by Petar JesicParkinson disease by Petar Jesic
Parkinson disease by Petar JesicPetar Jesic
 

Andere mochten auch (20)

Medicinal chemistry-beta lactam antibiotics
Medicinal chemistry-beta lactam antibioticsMedicinal chemistry-beta lactam antibiotics
Medicinal chemistry-beta lactam antibiotics
 
Basic aspects of Stereochemistry
Basic aspects of StereochemistryBasic aspects of Stereochemistry
Basic aspects of Stereochemistry
 
Medicinal chemistry
Medicinal chemistry Medicinal chemistry
Medicinal chemistry
 
Medicinal chemistry i
Medicinal chemistry  iMedicinal chemistry  i
Medicinal chemistry i
 
04.pharmacokinetics(1)
04.pharmacokinetics(1)04.pharmacokinetics(1)
04.pharmacokinetics(1)
 
Medicinal chemistry of Antiamoebic agents
Medicinal chemistry of Antiamoebic agentsMedicinal chemistry of Antiamoebic agents
Medicinal chemistry of Antiamoebic agents
 
Sulfonamides
SulfonamidesSulfonamides
Sulfonamides
 
medicinal chemistry of Antibiotic
medicinal chemistry of Antibiotic medicinal chemistry of Antibiotic
medicinal chemistry of Antibiotic
 
Cephalosporins- History,Classification,Sar,Synthesis,Mechanism of action,Uses...
Cephalosporins- History,Classification,Sar,Synthesis,Mechanism of action,Uses...Cephalosporins- History,Classification,Sar,Synthesis,Mechanism of action,Uses...
Cephalosporins- History,Classification,Sar,Synthesis,Mechanism of action,Uses...
 
Treament of malaria
Treament of malariaTreament of malaria
Treament of malaria
 
Mef n Taf Care Pack 1 3 mef and taf vets brief as at 8 feb 2016
Mef n Taf Care Pack 1 3 mef and taf vets brief as at 8 feb 2016Mef n Taf Care Pack 1 3 mef and taf vets brief as at 8 feb 2016
Mef n Taf Care Pack 1 3 mef and taf vets brief as at 8 feb 2016
 
Malaria+parasites
Malaria+parasitesMalaria+parasites
Malaria+parasites
 
Antimalarials
AntimalarialsAntimalarials
Antimalarials
 
Lifecycle of malarial parasite
Lifecycle  of  malarial  parasite Lifecycle  of  malarial  parasite
Lifecycle of malarial parasite
 
Malarial parasite
Malarial parasiteMalarial parasite
Malarial parasite
 
Reaxys Medicinal Chemistry
Reaxys Medicinal ChemistryReaxys Medicinal Chemistry
Reaxys Medicinal Chemistry
 
Anti viral drugs
Anti viral drugsAnti viral drugs
Anti viral drugs
 
Alcohol and drugs week 6
Alcohol and drugs week 6Alcohol and drugs week 6
Alcohol and drugs week 6
 
Acids and hallucigens
Acids and hallucigensAcids and hallucigens
Acids and hallucigens
 
Parkinson disease by Petar Jesic
Parkinson disease by Petar JesicParkinson disease by Petar Jesic
Parkinson disease by Petar Jesic
 

Ähnlich wie Medicinal chemistry- antimalerial agents

Ähnlich wie Medicinal chemistry- antimalerial agents (20)

Antimalerial agent.pdf
Antimalerial agent.pdfAntimalerial agent.pdf
Antimalerial agent.pdf
 
Antimalarial drugs
Antimalarial drugsAntimalarial drugs
Antimalarial drugs
 
Anti-malarial drugs [Drugs used for Malaria].pptx slide share
Anti-malarial drugs [Drugs used for Malaria].pptx slide share Anti-malarial drugs [Drugs used for Malaria].pptx slide share
Anti-malarial drugs [Drugs used for Malaria].pptx slide share
 
Antiprotozoal Drugs.ppt
Antiprotozoal Drugs.pptAntiprotozoal Drugs.ppt
Antiprotozoal Drugs.ppt
 
Antimalarial
AntimalarialAntimalarial
Antimalarial
 
Antimalarial Drugs Pharmacology
Antimalarial Drugs PharmacologyAntimalarial Drugs Pharmacology
Antimalarial Drugs Pharmacology
 
Anti-malarial Drugs
Anti-malarial DrugsAnti-malarial Drugs
Anti-malarial Drugs
 
Antimalarial drugs
Antimalarial drugsAntimalarial drugs
Antimalarial drugs
 
antimalarial drugs.pptx
antimalarial drugs.pptxantimalarial drugs.pptx
antimalarial drugs.pptx
 
Antiprotozoal drugs
Antiprotozoal drugsAntiprotozoal drugs
Antiprotozoal drugs
 
Pharmacology of anti malarial drugs
Pharmacology of anti malarial drugsPharmacology of anti malarial drugs
Pharmacology of anti malarial drugs
 
PRESENTATION ON ANTI-MALARIAL DRUGS.pptx
PRESENTATION ON ANTI-MALARIAL DRUGS.pptxPRESENTATION ON ANTI-MALARIAL DRUGS.pptx
PRESENTATION ON ANTI-MALARIAL DRUGS.pptx
 
ANTI-MALARIA DRUGS.pptx
ANTI-MALARIA DRUGS.pptxANTI-MALARIA DRUGS.pptx
ANTI-MALARIA DRUGS.pptx
 
Antimalarial drugs (VK)
Antimalarial drugs (VK)Antimalarial drugs (VK)
Antimalarial drugs (VK)
 
DRUG OF MALARIA PPT.pptx
DRUG OF MALARIA PPT.pptxDRUG OF MALARIA PPT.pptx
DRUG OF MALARIA PPT.pptx
 
Malaria presentation
Malaria presentationMalaria presentation
Malaria presentation
 
Anilmal drug
Anilmal drugAnilmal drug
Anilmal drug
 
Antimalerial
AntimalerialAntimalerial
Antimalerial
 
Chemotherapy of maleria
Chemotherapy of maleriaChemotherapy of maleria
Chemotherapy of maleria
 
Antimalarial drugs
Antimalarial drugsAntimalarial drugs
Antimalarial drugs
 

Kürzlich hochgeladen

AUTONOMIC NERVOUS SYSTEM organization and functions
AUTONOMIC NERVOUS SYSTEM organization and functionsAUTONOMIC NERVOUS SYSTEM organization and functions
AUTONOMIC NERVOUS SYSTEM organization and functionsMedicoseAcademics
 
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdfPAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdfDolisha Warbi
 
CPR.nursingoutlook.pdf , Bsc nursing student
CPR.nursingoutlook.pdf , Bsc nursing studentCPR.nursingoutlook.pdf , Bsc nursing student
CPR.nursingoutlook.pdf , Bsc nursing studentsaileshpanda05
 
Unit I herbs as raw materials, biodynamic agriculture.ppt
Unit I herbs as raw materials, biodynamic agriculture.pptUnit I herbs as raw materials, biodynamic agriculture.ppt
Unit I herbs as raw materials, biodynamic agriculture.pptPradnya Wadekar
 
"Radical excision of DIE in subferile women with deep infiltrating endometrio...
"Radical excision of DIE in subferile women with deep infiltrating endometrio..."Radical excision of DIE in subferile women with deep infiltrating endometrio...
"Radical excision of DIE in subferile women with deep infiltrating endometrio...Sujoy Dasgupta
 
blood bank management system project report
blood bank management system project reportblood bank management system project report
blood bank management system project reportNARMADAPETROLEUMGAS
 
Different drug regularity bodies in different countries.
Different drug regularity bodies in different countries.Different drug regularity bodies in different countries.
Different drug regularity bodies in different countries.kishan singh tomar
 
Role of Soap based and synthetic or syndets bar
Role of  Soap based and synthetic or syndets barRole of  Soap based and synthetic or syndets bar
Role of Soap based and synthetic or syndets barmohitRahangdale
 
ANATOMICAL FAETURES OF BONES FOR NURSING STUDENTS .pptx
ANATOMICAL FAETURES OF BONES  FOR NURSING STUDENTS .pptxANATOMICAL FAETURES OF BONES  FOR NURSING STUDENTS .pptx
ANATOMICAL FAETURES OF BONES FOR NURSING STUDENTS .pptxWINCY THIRUMURUGAN
 
Generative AI in Health Care a scoping review and a persoanl experience.
Generative AI in Health Care a scoping review and a persoanl experience.Generative AI in Health Care a scoping review and a persoanl experience.
Generative AI in Health Care a scoping review and a persoanl experience.Vaikunthan Rajaratnam
 
Mental health Team. Dr Senthil Thirusangu
Mental health Team. Dr Senthil ThirusanguMental health Team. Dr Senthil Thirusangu
Mental health Team. Dr Senthil Thirusangu Medical University
 
Using Data Visualization in Public Health Communications
Using Data Visualization in Public Health CommunicationsUsing Data Visualization in Public Health Communications
Using Data Visualization in Public Health Communicationskatiequigley33
 
Neurological history taking (2024) .
Neurological  history  taking  (2024)  .Neurological  history  taking  (2024)  .
Neurological history taking (2024) .Mohamed Rizk Khodair
 
Adenomyosis or Fibroid- making right diagnosis
Adenomyosis or Fibroid- making right diagnosisAdenomyosis or Fibroid- making right diagnosis
Adenomyosis or Fibroid- making right diagnosisSujoy Dasgupta
 
SGK RỐI LOẠN KALI MÁU CỰC KỲ QUAN TRỌNG.pdf
SGK RỐI LOẠN KALI MÁU CỰC KỲ QUAN TRỌNG.pdfSGK RỐI LOẠN KALI MÁU CỰC KỲ QUAN TRỌNG.pdf
SGK RỐI LOẠN KALI MÁU CỰC KỲ QUAN TRỌNG.pdfHongBiThi1
 
SGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA .pdf
SGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA    .pdfSGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA    .pdf
SGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA .pdfHongBiThi1
 
Red Blood Cells_anemia & polycythemia.pdf
Red Blood Cells_anemia & polycythemia.pdfRed Blood Cells_anemia & polycythemia.pdf
Red Blood Cells_anemia & polycythemia.pdfMedicoseAcademics
 
AORTIC DISSECTION and management of aortic dissection
AORTIC DISSECTION and management of aortic dissectionAORTIC DISSECTION and management of aortic dissection
AORTIC DISSECTION and management of aortic dissectiondrhanifmohdali
 
CONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdf
CONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdfCONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdf
CONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdfDolisha Warbi
 

Kürzlich hochgeladen (20)

AUTONOMIC NERVOUS SYSTEM organization and functions
AUTONOMIC NERVOUS SYSTEM organization and functionsAUTONOMIC NERVOUS SYSTEM organization and functions
AUTONOMIC NERVOUS SYSTEM organization and functions
 
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdfPAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
 
CPR.nursingoutlook.pdf , Bsc nursing student
CPR.nursingoutlook.pdf , Bsc nursing studentCPR.nursingoutlook.pdf , Bsc nursing student
CPR.nursingoutlook.pdf , Bsc nursing student
 
Biologic therapy ice breaking in rheumatology, Case based approach with appli...
Biologic therapy ice breaking in rheumatology, Case based approach with appli...Biologic therapy ice breaking in rheumatology, Case based approach with appli...
Biologic therapy ice breaking in rheumatology, Case based approach with appli...
 
Unit I herbs as raw materials, biodynamic agriculture.ppt
Unit I herbs as raw materials, biodynamic agriculture.pptUnit I herbs as raw materials, biodynamic agriculture.ppt
Unit I herbs as raw materials, biodynamic agriculture.ppt
 
"Radical excision of DIE in subferile women with deep infiltrating endometrio...
"Radical excision of DIE in subferile women with deep infiltrating endometrio..."Radical excision of DIE in subferile women with deep infiltrating endometrio...
"Radical excision of DIE in subferile women with deep infiltrating endometrio...
 
blood bank management system project report
blood bank management system project reportblood bank management system project report
blood bank management system project report
 
Different drug regularity bodies in different countries.
Different drug regularity bodies in different countries.Different drug regularity bodies in different countries.
Different drug regularity bodies in different countries.
 
Role of Soap based and synthetic or syndets bar
Role of  Soap based and synthetic or syndets barRole of  Soap based and synthetic or syndets bar
Role of Soap based and synthetic or syndets bar
 
ANATOMICAL FAETURES OF BONES FOR NURSING STUDENTS .pptx
ANATOMICAL FAETURES OF BONES  FOR NURSING STUDENTS .pptxANATOMICAL FAETURES OF BONES  FOR NURSING STUDENTS .pptx
ANATOMICAL FAETURES OF BONES FOR NURSING STUDENTS .pptx
 
Generative AI in Health Care a scoping review and a persoanl experience.
Generative AI in Health Care a scoping review and a persoanl experience.Generative AI in Health Care a scoping review and a persoanl experience.
Generative AI in Health Care a scoping review and a persoanl experience.
 
Mental health Team. Dr Senthil Thirusangu
Mental health Team. Dr Senthil ThirusanguMental health Team. Dr Senthil Thirusangu
Mental health Team. Dr Senthil Thirusangu
 
Using Data Visualization in Public Health Communications
Using Data Visualization in Public Health CommunicationsUsing Data Visualization in Public Health Communications
Using Data Visualization in Public Health Communications
 
Neurological history taking (2024) .
Neurological  history  taking  (2024)  .Neurological  history  taking  (2024)  .
Neurological history taking (2024) .
 
Adenomyosis or Fibroid- making right diagnosis
Adenomyosis or Fibroid- making right diagnosisAdenomyosis or Fibroid- making right diagnosis
Adenomyosis or Fibroid- making right diagnosis
 
SGK RỐI LOẠN KALI MÁU CỰC KỲ QUAN TRỌNG.pdf
SGK RỐI LOẠN KALI MÁU CỰC KỲ QUAN TRỌNG.pdfSGK RỐI LOẠN KALI MÁU CỰC KỲ QUAN TRỌNG.pdf
SGK RỐI LOẠN KALI MÁU CỰC KỲ QUAN TRỌNG.pdf
 
SGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA .pdf
SGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA    .pdfSGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA    .pdf
SGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA .pdf
 
Red Blood Cells_anemia & polycythemia.pdf
Red Blood Cells_anemia & polycythemia.pdfRed Blood Cells_anemia & polycythemia.pdf
Red Blood Cells_anemia & polycythemia.pdf
 
AORTIC DISSECTION and management of aortic dissection
AORTIC DISSECTION and management of aortic dissectionAORTIC DISSECTION and management of aortic dissection
AORTIC DISSECTION and management of aortic dissection
 
CONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdf
CONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdfCONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdf
CONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdf
 

Medicinal chemistry- antimalerial agents

  • 1. ANTIMALARIAL AGENTS PREPARED BY: MR. DHARMENDRASINH A. BARIA ASSISTANT PROFESSOR, DEPARTMENT OF PHARMACEUTICAL CHEMISTRY SMT. S. M. SHAH PHARMACY COLLEGE, MAHEMDABAD
  • 2. INTRODUCTION • Malaria, one of the most widespread diseases, is caused by a plasmodium parasite and is transmitted to humans by the female anopheles mosquito. Plasmodium belongs to the class of protozoa known as sporozoa. • Mainly four species of plasmodium typically cause human malaria are plasmodium falciparum, p. Vivax, P. Malariae and P. Ovale . • A 5th species, P. Knowlesi, is primarily a pathogen of monkeys, but has recently been recognized to cause illness, including severe disease, in humans in asia. • Although all species may cause significant illness, p. Falciparum is responsible for the majority of serious complications and death.
  • 3. LIFE CYCLE OF THE MALARIAL PARASITE
  • 4. • An anopheles mosquito inoculates plasmodium sporozoites to initiate human infection. Circulating sporozoites rapidly invade liver cells, and exoerythrocytic stage tissue schizonts mature in the liver. Merozoites are subsequently released from the liver and invade erythrocytes. • Only erythrocytic parasites cause clinical illness. Sexual stage gametocytes also develop in erythrocytes before being taken up by mosquitoes, where they develop into infective sporozoites.
  • 5. THERAPEUTIC CLASSIFICATION 1. Causal prophylaxis: (primary tissue schizonticides) • Drugs prevent the maturation of or destroy the sporozoites within the infected hepatic cell- thus prevent erythrocytic invasion • Primaquine, proguanil • Primaquine – for all species of malaria but not used due to its toxic potential • Proguanil- primarily for P. Falciparum and not effective against P. Vivax (weak activity), rapid development of resistance 2. Supressives prophylaxis: • Supress the erythrocytic phase and thus attack of malarial fever can be used as prophylactics • Chloroquine, proguanil, mefloquine, doxycycline
  • 6. 3. Clinical cure: Erythrocytic Schizonticides • Erythrocytic schizontocides are used to terminate episodes of malarial fever • Fast acting high efficacy drugs: • Chloroquine, quinine, mefloquine, halofantrine, artemicinin • Used singly to treat malaria fever • Faster acting, preferably used in falciparum malaria where delayed treatment may lead to death even if parasites are clear from blood • Slow acting low efficacy drugs: • Proguanil, pyrimethamine, sulfonamides, tetracyclines • Used only in combination
  • 7. 4. Radical curatives: • Drug attack exoerythrocytic stage (hypnozoites) given with clinical curative for the total eradication of the parasite from the patient’s body • Radical cure of the P. Falciparum malaria can be achieved by suppressives only • For radical cure of P. Vivax infection, primaquine and proguanil are effective 5. Gametocidal: • Removal of male and female gametes of plasmodia formed in the patient’s blood • It has no benefit for treated patient • Primaquine and artemisinins are highly effective against gametocytes of all species
  • 8. CHEMICAL CLASSIFICATION Classes Drugs 1. 4-aminoquinolines Chloroquine (CQ), amodiaquine (AQ), Piperaquine 2. Quinoline-methanol Mefloquine 3. Cinchona alkaloid Quinine, quinidine 4. Biguanide Proguanil (chloroguanide) 5. Diaminopyrimidine Pyrimethamine 6. 8-aminoquinoline Primaquine, tafenoquine 7. Sulfonamides and sulfone Sulfadoxine, sulfamethopyrazine, dapsone 8. Amino alcohols Halofantrine, lumefantrine
  • 9. 10. Naphthyridine Pyronaridine 11. Naphthoquinone Atovaquone 12. Antibiotics Tetracycline, Doxycycline, Clindamycin
  • 10. 1. 4-AMINOQUINOLINES N NH CH3 N C2H5 C2H5 Cl Chloroquine N NH C H 3 N C 2 H 4 O H C 2 H 5 C l H y d r o x y c h l o r o q u i n e NCl NH NH C2H5 C2H5 OH Amodiaquine
  • 11. CHLOROQUINE: • It has activity against the blood stages of plasmodium ovale, P. Malariae, and susceptible strains of P. Vivax and P. Falciparum. • Widespread resistance in most malaria-endemic countries has led to decline in its use for the treatment of p. Falciparum, although it remains effective for treatment of P. Ovale, P. Malariae and, in most regions, P. Vivax. • Mechanism of action : • Binds to and inhibits dna and rna polymerase; interferes with metabolism and hemoglobin utilization by parasites; inhibits prostaglandin effects. • The parasite digests the human hemoglobin in order to get amino acid, but the problem here is that the heme part of hb is toxic to the parasite.
  • 12. • To overcome this obstacle, the parasite has developed an enzyme responsible for polymerization of heme. To form insoluble crystals called hemozoin which are collected in vacuoles. • Chloroquine enters parasite cell by simple diffusion. Chloroquine then becomes protonated as the digestive vacuole is known to be acidic (pH 4.7), chloroquine then cannot leave by diffusion. Chloroquine inhibits polymerization of heme and accumulation of heme. • Chloroquine binds to heme (or fp) to form what is known as the fp-chloroquine complex, this complex is highly toxic to the cell and disrupts membrane function. Action of the toxic compound results in cell lysis and ultimately parasite cell autodigestion.
  • 15. • RESISTANCE RESULTS FROM ENHANCED EFFLUX OF THE PARASITE VESICLE EXPRESSION OF THE HUMAN MULTI DRUG RESISTANCE TRANSPORTER P- GLYCOPROTEIN.
  • 16. PHARMACOLOGICAL ACTIONS 1. Antimalarial activity: • High against erythrocytic forms of vivax, ovale, malariae & sensitive strains of falciparum • Gametocytes of vivax • No activity against tissue schizonts • Resistance develops due to efflux mechanism 2. Other parasitic infections: • Giardiasis, taeniasis, extrainstestinal amoebiasis 3. Other actions: • Depressant action on myocardium, direct relaxant effect on vascular smooth muscles, antiinflammatory, antihistaminic , local anaesthetic
  • 17. Adverse drug reactions Intolerance: • Nausea, vomiting, anorexia • skin rashes, angioneurotic edema, photosensitivity, pigmentation, exfoliative dermatititis • Long term therapy may cause bleaching of hair • Rarely thrombocytopenia, agranulocytosis, pancytopenia Ocular toxicity: • High dose prolonged therapy • Temporary loss of accommodation • Lenticular opacities, subcapsular cataract
  • 18. Adverse drug reactions • Retinopathy: • Constriction of arteries, edema, blue black pigmentation, constricted field of vision. • CNS: • Insomnia, transient depression seizures, rarely neuromyopathy & ototoxicity • CVS: • ST & T wave abnormalities, abrupt fall in bp & cardiac arrest in children reported
  • 19. THERAPEUTIC USES 1. HEPATIC AMOEBIASIS 2. GIARDIASIS 3. CLONORCHIS SINENSIS 4. RHEUMATOID ARTHRITIS 5. DISCOID LUPUS ERYTHEMATOSUS 6. CONTROL MANIFESTATION OF LEPRA REACTION 7. INFECTIOUS MONONUCLEOSIS
  • 20. • Hydroxy chloroquine:  Less toxic, properties &uses similar • Amodiaquine:  As effective as chloroquine  Pharmacological actions similar  Chloroquine resistant strains may be effective  Adverse events: GIT, headache , photosensitivity, rarely agranulocytosis  Not recommended for prophylaxis
  • 21. • Contraindications: 1.Psoriasis or porphyria 2.Visual field abnormalities or myopathy 3.Ca and mg containing antacid interfere with absorption 4.Used with caution in liver disease or neurologic or hematologic disorders.
  • 22. N NHR R1 Cl 1 2 3 45 6 7 8 Dialkylaminoalkyl side chain 1. 2-5 carbon atoms between the nitrogen atoms,particularly 4-diethylamino- 1-methylbutylamino side chain is optimal for activity as in chloroquine. 2. The tertiary amine is important. 3. Introduction of unsaturation in the side chain was not detrimental to activity. 4. Substitution of a hydroxy on one of the ethyl groups in tertiary amine (hydroxy quinoline) generally reduces toxicity and increases the plasma concentration. This is one of the metabolites of chloroquine. 5. Incorporation of an aromatic ring in the side chain e.g. in Amodiaquine, gives a compound with reduced toxicity and toxicity. Introduction of chloro group at this position is optimal for activity Introduction of methyl group at this position reduces activity d-Isomer of chloroquine is somewhat less toxic than l-isomer SAR of 4-aminoquinolines
  • 23. 2. QUINOLINE-METHANOL N CF3 NH OH H CF3 Mefloquine  Mefloquine, is marketed as the R,S-isomer.  Mefloquine's effectiveness in the treatment and prophylaxis of malaria is due to the destruction of the asexual blood forms of the malarial pathogens that affect humans, Plasmodium falciparum, P. vivax, P. malariae, P. ovale.  Used in chloroquine-resistant strains of P. falciparum and other species.  Has strong blood schizonticidal activity against P. falciparum and P. vivax, it is not active against hepatic stages or gametocytes. Adverse effects  Mefloquine is bitter in taste  At high doses: Nausea, vomiting, diarrhea, abdominal pain,
  • 24. CONTRAINDICATIONS • Hypersensitivity to mefloquine, related compounds (eg, quinine and quinidine), or any component of the formulation; prophylactic use in patients with a history of seizures or severe psychiatric disorder (including active or recent history of depression, generalized anxiety disorder, psychosis, or schizophrenia). Drug interactions • Cardiac arrests are possible if mefloquine is taken concurrently with quinine or quinidine. Uses • Effective for multidrug resistant p. Falciparum • However its use is restricted due to its toxicity, cost and long half life
  • 25. 3. CINCHONA ALKALOIDS N OH N H R2 R1 1 2 3 45 6 7 8 1 2 3 4 5 6 7 8 9 • Quinine is a l-isomer of alkaloid obtained from cinchona bark and quinidine (antiarrhythmic) is its d-isomer. • An effective erythrocytic schizontocide as suppressive and used to prevent or terminate attacks of vivax, ovale, malariae, sensitive falciparum. less effective and more toxic than chloroquine. • Moderately effective against hepatic form (pre-exoerythrocyte and gametocytes).
  • 26. PHARMACOLOGICAL ACTIONS 1. Antimalarial action: • Erythrocytic forms of all malarial parasites including resistant falciparum strains . • Gametocidal for vivax & malariae 2. Cardiovascular: • Depresses myocardium, ↓ excitability, ↓ conductivity, ↑ refractory period, profound hypotension IV. 3. Miscellaneous actions: • Mild analgesic, antipyretic activity , stimulation of uterine smooth muscle, curaremimitic effect 4. Local irritant and anaesthetic
  • 27. • Resurgence of interest in quinine is due to the fact that most chloroquine and multidrug-resistant strains of P. Falciparum still respond to it. • Quinine + tetracycline has been the standard treatment of complicated malaria. Adverse drug reactions Cinchonism: • Tinnitus, nausea & vomiting. • Headache mental confusion, vertigo, difficulty in hearing & visual disturbances • Diarrhoea , flushing & marked perspiration. • Still higher doses, exaggerated symptoms with delirium, fever, tachypnoea, respiratory depression, cyanosis.
  • 28. Black water fever: a fatal condition in which acute hemolytic anemia is associated with renal failure. Cardiovascular toxicity: cardiac arrest, hypotension ,fatal arrhythmias Black water fever because of methanol group CONTRAINDICATIONS : Hypersensitivity to quinine or any component of the formulation; hypersensitivity to mefloquine or quinidine (cross sensitivity reported); prolonged QT interval; myasthenia gravis; optic neuritis; G6PD deficiency; history of black water fever; thrombotic thrombocytopenia purpurea, hemolytic uremic syndrome, thrombocytopenia
  • 29. N N OH H R1 H 1' 2' 3'4' 5' 6' 7' 8' 9 1 2 3 4 5 6 7 8 Assymmetry at this positions is not essential for antimalarial activity Quinuclidine portion is not necessary for activity; however, an alkyl tertiary amine attached at C-9 is important 1. Modification of the secondary alcohol at C-9, through oxidation, esterification diminishes activity. 2.The configuration at positions 8 and 9 affects the juxtaposition of the hydroxyl group and the non-aromatic nitrogen atom, a relationship that is associated with antimalarial activity. Activity usually enhanced by the introduction of a halogen at this position. Quinoline Ring 1. Presence of methoxy group in quinine is not essential. 2. Replacement of methoxy group by a halogen, especially chlorine, enhances activity. 3. A further increase in activity resulted from the introduction of a phenyl group at position 2'. 4. It was discovered that high activity without phototoxicity could be attained by blocking position 2' with a trifluoromethyl group, a finding that eventually led to development of mefloquine. SAR Of Quinine
  • 30. 4. BIGUANIDES N H NH2N H NH2 NH CH (CH3)2 Proguanil  It is an early example of a prodrug.  It is a slow-acting erythrocytic schizontocide which also inhibits the preerythrocytic stage of P. falciparum. Gametocytes exposed to proguanil are not killed but fail to develop properly in the mosquito.  It is cyclized in the body to a triazine derivative (cycloguanil) which inhibits plasmodial DHFRase in preference to the mammalian enzyme.  Resistance to proguanil develops rapidly due to mutational changes in the plasmodial DHFRase enzyme.
  • 31. Conversion of proguanil to cycloguanil by CYP2C19
  • 32. Adverse effects • Mild abdominal upset, vomiting • Occasional stomatitis • Haematuria, rashes and transient loss of hair • Note : safe during pregnancy
  • 33. Mechanism of action of anti folates
  • 34. 5. DIAMINOPYRIMIDINE C H2 N N NH2 NH2 MeO MeO MeO N N NH2 Cl NH2 C2 H5 Trimethoprim Pyrimethamine  Slow acting erythrocytic schizontocide  Direct inhibitor of plasmodial dihydrofolate reductase (DHFRase)  Conversion of dihydrofolic acid to tetrafolic acid is inhibited  High doses inhibits Toxoplasma gondi  Resistance develops by mutation in DHFRase enzyme  Diaminopyrimidine more potent than proguanil & effective against erythrocytic forms of all species.
  • 35. Pyrimethamine Adverse effects • Occasional nausea and rashes • Folate deficiency rare • Megaloblastic anaemia and granulocytopenia with higher dose • Can be treated with folinic acid • Combined with a sulfonamide (S/P) or dapsone for treatment of falciparum malaria
  • 36. SULFADOXINE - PYRIMETHAMINE • Sequential blockade • Sulfadoxine 500 mg + pyrimethamine 25 mg, 3 tablets once for acute attack • Not recommended for prophylaxis • Effective blood schizontocide against plasmodium falciparum • Treatment and prophylaxis of falciparum malaria resistant to chloroquine
  • 37. Adverse effects • Mild GIT upset • Megaloblastic anemia, bone marrow depletion • Rashes, urticaria, serum sickness, drug fever • Exfoliative dermatitis, stevens johnson syndrome • Nephrotoxicity Uses: • Single dose treatment of uncomplicated chloroquine resistant falciparum malaria • Patients intolerant to chloroquine • First choice treatment for toxoplasmosis
  • 39. Primaquine: • It is the only 8-aminoquinoline in clinical use. • It is largely used to prevent relapse of p. Ovale and P. Vivax malaria by eliminating dormant hypnozoites, and it also has activity against the pre-erythrocytic stage and gametocytes of P. Falciparum. • It is not used for prophylaxis. Its spectrum of activity is one of the narrowest of the currently used antimalarial drugs being indicated only for exoerythrocytic P. Vivax malaria Mechanism of action primaquine: • Not clear, its converted & produces active oxygen interfere with plasmodial mitochondrial function
  • 40. Uses of primaquine 1. Radical cure A) P.Vivax & ovale : • Given in acute attack or throughout incubation period • Prevents relapse Prophylactically: before & after leaving the endemic area to eradicate hepatic forms • Effective vector control is possible or used in areas of low transmission B) falciparum malaria: • 45mg with chloroquine used like gametocidal & cut down transmission or where effective control is needed.
  • 41. Adverse drug reaction Therapeutic doses: • Haemolysis & methaemoglobinaemia commonly seen in g6pd deficiency • Causes nausea, headache, epigastric pain &abdominal cramps on empty stomach • Rarely : leucopenia, leucocytosis & agranulocytosis • Precaution – primaquine • Should not be given during pregnancy because fetus is glucose-6-phosphate dehydrogenase ( g-6-pd) deficient
  • 42. 7. SULFONAMIDES AND SULFONE Dapsone N N NH2 S N H O O OMeMeO Sulfadoxine 8. Amino alcohols
  • 43. • Structurally, halofantrine differs from all other antimalarial drugs. It is a good example of drug design that incorporates bioisosteric principles as evidenced by the trifluromethyl moiety. • Halofantrine is a schizonticide and has no affect on the sporozoite, gametocyte,or hepatic stages. • It is active against strains resistant to chloroquine, pyrimethamine, quinine. • Cross-resistance in falicparum infection occurred . • Erratic bioavailability, lethal cardio toxicity & cross resistance to mefloquine limited its use. • Now a days used only when no other alternative available
  • 44. ADR:- • Abdominal pain, headache, transient increase in hepatic enzymes, cough, pruritus, lengthening of qt interval. May cause hemolytic anemia & convulsions. Reserved for infection caused by resistant organisms. Contraindications: with mefloquine. • Patients with cardiac conduction defects. • In pregnancy → embriotoxic in animals
  • 45. 9. SESQUITERPINE LACTONES • The artemisinin series are the newest of the antimalarial drugs and are structurally unique when compared with the compounds previously and currently used. • The parent compound, artemisinin, is a natural product extracted from the dry leaves of artemisia annua (sweet wormwood). • All of the compounds given in figure are active against the plasmodium genera that cause malaria. PLANT- ARTEMISIA ANNUA
  • 46. • The key structure characteristic appears to be a “trioxane” consisting of the endoperoxide and dioxepin oxygens. • Note that the stereochemistry at position 12 is not critical. • These are the artimisinin derivatives used in malaria: 1. Artesunate 2. Artemether 3. Arteether 4. Arterolane
  • 47. MECHANISM OF ACTION • These compounds contains endoperoxide bridge. • Endoperoxide bridge interacts with heme in parasite. • Heme iron cleaves this endoperoxide bridge. • There is generation of highly reactive free radicals which damage parasite membrane by covalently binding to membrane proteins.
  • 48. • They act rapidly, killing blood stages of all plasmodium species and reducing the parasite biomass. • Artemisinins have the fastest parasite clearance times of any antimalarial. • Artemisinins are active against gametocytes, the parasite form that is infectious to mosquitoes, and their use has been associated with reduced malaria transmission. • Safe & 10-100 times potent compared to other antimalarials.
  • 50. ARTEMISININ-BASED COMBINATION THERAPIES • In general, artemisinins should not be used as a single agent, to prevent emergence of drug resistance and to avoid the need for prolonged therapy. • Artemisinin-based combination therapy (acts) combine the highly effective short- acting artemisinins with a longer-acting partner to protect against artemisinin resistance and to facilitate dosing convenience. • Acts are typically administered for 3 days and are often available in fixed-dose tablets. • Four acts are recommended by the who for the treatment of uncomplicated malaria: artemether-lumefantrine, artesunate-amodiaquine, artesunate- mefloquine and artesunate-sulfadoxine-pyrimethamine.
  • 51. ARTEMISININS • Intravenous artesunate is used for the treatment of severe malaria. • It is superior to quinine for treatment of severe malaria with respect to clearing parasitemia and reducing mortality. • Given the short half-life of artemisinins, intravenous therapy must be followed by a longer acting agent once the patient is able to tolerate oral medication. • If used alone (via the parenteral, rectal or oral route), artesunate must be administered for 5-7 days. • Treatment for less than 5 days results in recurrent parasitemia several weeks after therapy due to the very short duration of action, rather than to artemisinin resistance.
  • 52. • Artemisinins are generally well tolerated. • Type 1 hypersensitivity to the artemisinin compounds has been reported. • Adverse effects of orally-administered artemisinins demonstrated transient neurological abnormalities (nystagmus and disturbances in balance); these effects resolved without lasting sequelae. Advantages of act • Rapid clinical and parasitological cure • High cure rates(>95%) and low recrudescence rate • Absence of parasite resistance • Good tolerability profile • Dosing schedule is simpler
  • 53. 1. ARTESUNATE - SULFADOXINE + PYRIMETHAMINE (AS-S/P) • First line drug for uncomplicated falciparum malaria. • Not effective against multidrug-resitant strains which are non responsive to s/p. • Fewer side effects than as/mq.2. Artesunate /mefloquine (AS/MQ) • Highly effective and well tolerated in uncomplicated falciparum malaria 3. Artemether - lumefantrine (AS/LF)  Clinical efficacy: 95-99%  Must be administered with fatty food or milk to allow absorption and ensure adequate blood level of AS/LF  Quickly reduces parasite biomass, resolve symptoms, prevent recrudescence, check gametocyte population
  • 54. 4. DIHYDROARTEMISININ (DHA)-PIPERAQUINE • Used in dose ratio of 8:1 for multidrug resistant plasmodium falciparum. • Good safety profile and even tolerated by children (>98% response rate). 5. ARTESUNATE-AMODIAQUINE(AS/AQ) • First line therapy of uncomplicated falciparum malaria • To be taken twice daily for three day treatment Other recently developed ACT are: 6. ARTEROLANE-PIPERAQUINE • Acts rapidly at all stages of asexual schizogony of malarial parasite including multidrug resistant P. Falciparum 7. ARTESUNATE-PYRONARIDINE • Under clinical trial
  • 55. 10. NAPHTHYRIDINE  Newer drug from Mepacrine developed in china.  Mechanism similar to chloroquine.  High effective erythrocytic schizonticide, effective against chloroquine sensitive & resistant vivax & falciparum malaria.  Slow onset & long duration of action, concentrated in RBC.  Water soluble, t1/2 : 7days  Orally & parenterally used , well tolerated  At high dose used analgesic/anti pyretic
  • 56. 11. NAPHTHOQUINONE  Hydroxy naphthoquinone antiparasitic drug active against all Plasmodium species.  Rapid acting erythrocytic schizontocide & inhibits pre- erythrocytic stage of falciparum.  Also active against pneumocystis jiroveci & Toxoplasma gondii.  Combined with proguanil Where its resistant, reduces relapse & which is synergistic.  Collapses mitochondrial membrane interferes with cytochrome electron transport.
  • 57. 12. ANTIBIOTICS Tetracycline & doxycycline  Erythrocytic schizonts are inhibited by all malarial parasite.  Tetracycline used in combination with quinine in treatment of chloroquine resistant as well vivax malaria.  Avoid in children & pregnant women.  Doxycycline used in places where high resistance present.  200mg doxycycline combined with artesunate to treat mefloquine/chloroquine/s-p resistant malaria.  100mg/day of doxycycline used 2nd line prophylactic for short travels to chloroquine resistant p. Falciparum.
  • 58. CLINDAMYCIN: • Slow erythrocytic schizontocide, bacteriostatic • With quinine used in treatment of resistant P.Falciparum • Its used where tetracyclines can not be used in pregnancy & children less than 8 years old